Androgen receptor defects: historical, clinical, and molecular perspectives - sprookjes - yvandenbroek - TriplyDB

Androgen receptor defects: historical, clinical, and molecular perspectives

Androgen receptor defects: historical, clinical, and molecular perspectives

http://www.wikidata.org/entity/Q28297256

about

Anogenital distance in human male and female newborns: a descriptive, cross-sectional study Novel phytoandrogens and lipidic augmenters from Eucommia ulmoides DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor Novel ATPase of SNF2-like protein family interacts with androgen receptor and modulates androgen-dependent transcription A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4 A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression Modulation of androgen receptor transactivation by FoxH1. A newly identified androgen receptor corepressor Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription.A novel function of caspase-8 in the regulation of androgen-receptor-driven gene expression Testosterone activates mitogen-activated protein kinase and the cAMP response element binding protein transcription factor in Sertoli cells Androgen receptor molecular biology and potential targets in prostate cancer Human checkpoint protein hRad9 functions as a negative coregulator to repress androgen receptor transactivation in prostate cancer cells Activation of androgen receptor function by a novel nuclear protein kinase Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity Characterization of nuclear import of the domain-specific androgen receptor in association with the importin alpha/beta and Ran-guanosine 5'-triphosphate systems Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go Fingers as a marker of prenatal androgen exposure Assessment of the gonadotrophin-gonadal axis in androgen insensitivity syndrome Phenotypic diversity in siblings with partial androgen insensitivity syndrome Environmental endocrine disruption: an effects assessment and analysis Differential gene-expression patterns in genital fibroblasts of normal males and 46,XY females with androgen insensitivity syndrome: evidence for early programming involving the androgen receptor Recognition and accommodation at the androgen receptor coactivator binding interface Membrane androgen binding sites are preferentially expressed in human prostate carcinoma cells Androgen actions on endothelium functions and cardiovascular diseases Health-Promoting Properties of Eucommia ulmoides: A Review Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications Disorders of sexual differentiation: II. Diagnosis and treatment Modulation of Androgen Receptor Activation Function 2 by Testosterone and Dihydrotestosterone X-Ray Crystal Structure of the Ancestral 3-Ketosteroid Receptor–Progesterone–Mifepristone Complex Shows Mifepristone Bound at the Coactivator Binding Interface Clinical management of infertile men with nonobstructive azoospermia Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription Activation function-1 domain of androgen receptor contributes to the interaction between subnuclear splicing factor compartment and nuclear receptor compartment. Identification of the p102 U5 small nuclear ribonucleoprotein particle-binding protein Androgen receptor specifically interacts with a novel p21-activated kinase, PAK6 Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome Tip110, the human immunodeficiency virus type 1 (HIV-1) Tat-interacting protein of 110 kDa as a negative regulator of androgen receptor (AR) transcriptional activation Male infertility and androgen receptor gene mutations: clinical features and identification of seven novel mutations p21-Activated kinase 6 (PAK6) inhibits prostate cancer growth via phosphorylation of androgen receptor and tumorigenic E3 ligase murine double minute-2 (Mdm2)CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1 Mutual transcriptional interference between RelA and androgen receptor

P2860

Q21245832-018F189E-FE20-4B2E-8839-6FBF3AF896E1 Q21254658-CEC07F0B-07E4-441B-A9A9-C31C032A224E Q24291490-B879CE45-3930-4E0A-AE09-7ED340AE3715 Q24299539-840987A0-24CE-416E-A1B2-08D31BC9D238 Q24304373-2A2B986D-4FA9-4176-872F-CEC31A8E1684 Q24306297-F5D62425-9A20-483C-98C9-CCC1EF5FBC6D Q24317585-20FA0077-3750-4158-94FC-0C05D235BB81 Q24329102-3FE54338-E60B-498A-8979-CC0BDDB11CB2 Q24336995-51DBA713-2C85-4A05-98DB-5875927F6D34 Q24563419-086D4EF7-FEA7-4C4F-89C8-3B655EAFCDCF Q24602861-FA392C10-BBC4-478F-9A12-AF09CA405601 Q24607572-7EEAD6C6-821E-451D-9A3F-355164C4DD6C Q24644935-4B6A7F84-4648-44FD-BBA4-D0EF1EBC0612 Q24647922-BBEB4D1F-6994-4FDF-86F2-74AC7A03622F Q24653761-BA3C39F1-8F1F-41D4-807A-A0339DB9948F Q24654156-FFBE2230-3036-47D2-96AB-29308EBA694C Q24656303-206112D6-1725-4594-BF44-5CCB8C1368E3 Q24657735-48615DB1-0387-4AEE-AB1D-CFB8187A8C0E Q24675932-54BDACDC-C6CD-467C-8132-2F890C0F925E Q24676294-70286988-F083-401D-811F-F026EEE4F747 Q24682441-8A9BCF4D-A95F-45F4-BA8E-E8838B32AC33 Q24796187-61CD1656-B16C-406D-A150-0C94826FD6D1 Q24799399-9A732E68-4EEA-469C-95B1-0AD7FD367ECE Q24800710-8BC4C644-9733-438D-96C1-4550E45D2881 Q26750657-370024DC-99D0-47FA-8508-E2A108A104B4 Q26752761-11B95D46-1A97-4092-8544-9A5D3359776C Q26797063-762FB79E-5C41-4F16-82B6-1014EC5F47B3 Q26853190-EF7C4891-A8BF-44D0-A05E-D237633EA57E Q27646416-74294836-61F0-49FC-A4B6-8AA48D26AC08 Q27680664-733DEE46-4D8E-4C53-9CE2-F8F80CAA1FFE Q28083691-84BFFC2E-4452-4B09-8006-089DF58EA28D Q28138255-5A1646DF-1B61-40AC-9C9F-EB71996B8165 Q28201872-33661228-64B5-4F31-84FD-6CBEF401FF4D Q28208123-A9C0F4D9-7FA9-4CA2-B321-6A4D76D58A7E Q28239675-2B4C2CF1-695A-4592-A557-20A38D0296DC Q28251356-2456CDBC-A657-4F3C-A57E-7309F2AA5B65 Q28269669-E5A6E362-8F1D-4248-B44A-749A243C82E4 Q28278797-EFCFBAD4-DF96-4794-8E55-50FCE8C8601C Q28289225-FCB87ABF-92C8-486C-996D-A9D4230D9E5B Q28289361-34A1DF00-70F3-4E9C-8945-4EAD6D8DA1AC

P2860

Androgen receptor defects: historical, clinical, and molecular perspectives

http://www.wikidata.org/entity/Q28297256

description

1995 nî lūn-bûn

@nan

1995 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Androgen receptor defects: historical, clinical, and molecular perspectives

@ast

Androgen receptor defects: historical, clinical, and molecular perspectives

@en

Androgen receptor defects: historical, clinical, and molecular perspectives

@nl

type

label

Androgen receptor defects: historical, clinical, and molecular perspectives

@ast

Androgen receptor defects: historical, clinical, and molecular perspectives

@en

Androgen receptor defects: historical, clinical, and molecular perspectives

@nl

prefLabel

Androgen receptor defects: historical, clinical, and molecular perspectives

@ast

Androgen receptor defects: historical, clinical, and molecular perspectives

@en

Androgen receptor defects: historical, clinical, and molecular perspectives

@nl

P1433

Q28297256-4001B15F-3698-4AB6-B63E-481BD6E5F518

P1476

Q28297256-D92B02E2-9E5D-405E-9687-AD82A59583E8

P2093

Q28297256-14197D78-3372-43DA-978E-36D7526208EE

Q28297256-2B957CBA-9093-4F34-9BFD-7DDEB83A1708

Q28297256-5472E016-E533-4E14-A98C-0C68CB47707D

Q28297256-561A3D45-CCD7-446A-9931-A686FCF3D358

Q28297256-C1BEB2E5-450E-4BFA-9B6D-531697571B6A

Q28297256-CB993CC8-6124-4FBF-AE78-8F053DA3F471

P304

Q28297256-D15AE45F-0583-44E5-B62C-89B1A4F06B93

P31

Q28297256-13C6F45A-63A6-4F1A-9B47-5D458B10B110

P3181

Q28297256-C62B0609-3DCC-41CC-818D-2046EA4C3BAA

P356

Q28297256-B731B99A-AABC-41AC-9026-B148E6D82BCB

Q28297256-DB828E56-004A-4A2C-BA6A-CCF705DADC02

P407

Q28297256-B5EC48B4-40EC-439A-8C24-4068B383EE72

P433

Q28297256-C86F5C90-ECB0-4D76-BFF5-04E36877A83C

P478

Q28297256-F634BA68-53E9-4F0A-B073-E6D01C3A7E19

P577

Q28297256-9921D4F6-1AE4-443C-8212-339DEA127454

P698

Q28297256-22D67E84-A719-449A-B866-CC4947F92006

P3181

P356

P1433

Endocrine Reviews

P1476

Androgen receptor defects: historical, clinical, and molecular perspectives

@en

P2093

A De Bellis

http://www.w3.org/2001/XMLSchema#string

C A Quigley

http://www.w3.org/2001/XMLSchema#string

E M Wilson

http://www.w3.org/2001/XMLSchema#string

F S French

http://www.w3.org/2001/XMLSchema#string

K B Marschke

http://www.w3.org/2001/XMLSchema#string

M K el-Awady

http://www.w3.org/2001/XMLSchema#string

P304

271-321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1946083

http://www.w3.org/2001/XMLSchema#string

P356

10.1210/EDRV-16-3-271

http://www.w3.org/2001/XMLSchema#string

10.1210/ER.16.3.271

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

1995-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7671849

http://www.w3.org/2001/XMLSchema#string